Amundi’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4M Buy
217,739
+153,029
+236% +$5.98M ﹤0.01% 873
2026
Q1
$2.29M Buy
64,710
+32,327
+100% +$1M ﹤0.01% 1080
2025
Q4
$906K Buy
32,383
+2,973
+10% +$89K ﹤0.01% 1295
2025
Q3
$911K Buy
29,410
+2,390
+9% +$67.4K ﹤0.01% 1177
2025
Q2
$784K Sell
27,020
-40,325
-60% -$1.2M ﹤0.01% 1248
2025
Q1
$2.13M Sell
67,345
-16,318
-20% -$532K ﹤0.01% 1134
2024
Q4
$2.38M Sell
83,663
-181,803
-68% -$5.23M ﹤0.01% 1145
2024
Q3
$7.2M Sell
265,466
-71,219
-21% -$1.9M ﹤0.01% 916
2024
Q2
$8.16M Buy
336,685
+28,013
+9% +$687K ﹤0.01% 882
2024
Q1
$7.33M Buy
308,672
+184,014
+148% +$5.23M ﹤0.01% 895
2023
Q4
$3.61M Buy
124,658
+1,248
+1% +$32.4K ﹤0.01% 1052
2023
Q3
$3.42M Buy
123,410
+108,554
+731% +$3.18M ﹤0.01% 1053
2023
Q2
$453K Sell
14,856
-3,279
-18% -$99.3K ﹤0.01% 1407
2023
Q1
$533K Buy
18,135
+2,485
+16% +$67.7K ﹤0.01% 1360
2022
Q4
$420K Sell
15,650
-69,635
-82% -$1.67M ﹤0.01% 1427
2022
Q3
$1.97M Buy
+85,285
New +$2.22M ﹤0.01% 1155
2021
Q4
Sell
-80,703
Closed -$2.49M 1671
2021
Q3
$2.49M Sell
80,703
-17,065
-17% -$482K ﹤0.01% 1154
2021
Q2
$2.4M Buy
+97,768
New +$2.17M ﹤0.01% 1134

Other funds holding ALKS

Amundi's ALKS Position: Q2 2026 in Review

Amundi increased its Alkermes (ALKS) stake by 236% in Q2 2026, buying an estimated $5.98M and bringing the position to 217,739 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #873.

Amundi first reported a position in ALKS in Q2 2021 and has held it in 18 quarters since. 425 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Amundi held 217,739 shares of Alkermes worth $11.4M as of Q2 2026.
  • Amundi bought 153,029 Alkermes shares in Q2 2026, an estimated $5.98M.
  • Alkermes made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #873 holding.
  • Amundi first reported a position in Alkermes in Q2 2021 and has held it in 18 quarters since.
  • 425 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.